INTRODUCTION
Signals provided by Epo and its single transmembrane receptor (EpoR) are essential for erythroblast formation 1 . Physicochemical studies have revealed unique mechanisms for Epo binding 2 , and conformation-dependent activation of EpoR-Jak2 kinase complexes 3 . Epo-activated signaling pathways also are well-studied 4 , yet gaps in knowledge persist concerning the nature of key signals for EpoR biofunction. Interest in this basic problem also is provoked by apparent EpoR cytoprotection of injured myocardial, neuronal, endothelial and renal cells, 5 and by the association of EpoR action with angiogenesis 5 , VHL carcinomas 6 , melanoma 7 , and myoma 8 formation. To better elucidate core signals for erythroid progenitor cells, we presently have performed first-time analyses of the signaling capacities of minimal knocked-in murine EpoR alleles in primary bone marrow-derived erythroblasts.
Epo binding occurs via Epo high-affinity A, B, D helix site-1, and low-affinity A, C helix site-2 interactions with bipartite seven beta-strand ligand binding sites in appositioned EpoR dimers 2 . Via a cytoplasmic juxtamembrane box-1 domain, the EpoR also preassembles with Jak2 kinase 9 . Epo-EpoR interactions stimulate Jak2 phosphorylation at Y1007/Y1008 sites 10 , and Jak2 (potentially in concert with Src, Btk, STK and/or Kit tyrosine kinases) [11] [12] [13] [14] [15] then mediates the phosphorylation of multiple EpoR cytoplasmic tyrosine motifs. In particular, within the EpoR of mouse, man and zebra fish, 16 and/or Syp/SH2-PTP2 18-22 ; PY429 and PY431 binding of SOCS-3 and/or SHP-1 23, 24 ; PY460 binding of CrkL 25 and regulation of intracellular calcium flux 26 ; PY464 and/or PY479 binding of Lyn 27 ;
and PY479 binding of alpha-p85/PI3 kinase 28 . In the human EpoR, an additional juxtamembrane only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013 . bloodjournal.hematologylibrary.org From cytoplasmic PY285 site also exists and has been demonstrated in 32D cells to modulate Stat5 and Stat1 activation 29 .
Based on the evolutionary conservation of these EpoR PY sites and their demonstrated role as an assembling scaffold for the above effectors 4 , EpoR phosphotyrosine motifs are predicted to be important for Epo's actions. The extent to which these EpoR regions (and linked pathways) act in central or perhaps only modulatory capacities, however, is controversial. This point is highlighted by the ability of PY-deficient EpoR alleles to support steady-state erythropoiesis in vivo 30 . Specifically, steady-state erythropoiesis in mice expressing a knocked-in PY-null EpoR-HM allele is affected to the extent that hematocrits are decreased ~8-points on average, and RBC counts are decreased ~ 15% 30 .
Unexpectedly, this suggests that core signals provided by Jak2 (in the absence of EpoR PY-signals)
efficiently support Epo-dependent erythroblast formation. These findings raise basic questions concerning the nature of core signaling pathways that are utilized by these minimal EpoR alleles (and the wt-EpoR). Due to the challenges of working with low abundance progenitor cells, however,
analyses of molecular signals relayed by minimal murine EpoR forms in bone marrow-derived erythroblasts are limited to date to single-point EMSA analyses of Stat5 activity 30 .
To address the above basic problems in Epo signaling, primary culture systems presently have been implemented to investigate Epo-activated signals in erythroblasts derived from adult bone marrow of mice expressing a PY-null EpoR-HM allele, or a related knocked-in EpoR-H allele in which a single PY343 Stat5 binding site is selectively restored 30 . These analyses provide several new lines of insight into signals that are relayed via EpoR-HM/Jak2 and EpoR-H/Jak2/Stat5 axes. Overall, core EpoRplus-Jak2-activated erythropoietic signals appear to be relayed primarily via Stat-5,-1,-3, JNK-and p70S6K-independent, but ERK 1,2-dependent routes. In expanded wt-EpoR, EpoR-HM and EpoR-H erythroblast preparations, Epo-induced Jak2 activation first was analyzed (Figure 1-B1 ). Hematopoietic cytokines were withdrawn (for 6 hours), and erythroblasts then were exposed to Epo (2.5U/mL) for the indicated intervals. Via each EpoR allele, Jak2 activation was rapid (>50% maximum activation by 3 minutes) and progressed over highly similar time-courses. To confirm this result, and to account for possible variable responsiveness among Ter119 pos subpopulations, analyses were repeated using Ter119-depleted preparations (and extended time-courses) (Figure 1-B2 ). Jak2 again was activated by the wt-EpoR, EpoR-HM and EpoR-H at similar levels, and rates. Differential Jak2 activation therefore does not appear to underlie differences in EpoR allele biosignaling capacities. No Epo-dependent activation of Jak1, Jak3 or Tyk2 was detected (data not shown).
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Epo receptor allele regulation of Akt, p70S6-kinase, p60-Src and MAPKs
In cell lines and in fetal liver cells, Akt and p70S6K each have been shown to be activated by Epo 28, 37, 38 . These response pathways are linked in that PI3-kinase stimulates Akt, Akt activates mTOR, and mTOR comprises a major p70S6K regulator 39, 40 . Each response also can affect progenitor cell survival only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 40 . p70S6K and Akt activation therefore was examined in primary EpoR-HM and EpoR-H erythroblasts. p70S6K was activated efficiently via the wt-EpoR, but was not significantly stimulated via EpoR-H or -HM alleles ( Figure 2A ). This outcome is consistent with an indicated role for an EpoR PY479 site recruitment of PI3-kinase upstream of p70S6K activation 28 (and p70S6K therefore may be non-essential for efficient EpoR function). For Akt, activation via EpoR-H and -HM alleles was diminished markedly, but each nonetheless activated Akt at residual levels (~ 20% of wt-EpoR levels)
( Figure 2B ). The extent to which this limited Akt activation may affect EpoR-H and EpoR-HM bioactivity is unclear.
p60-Src also has been demonstrated to interact with the EpoR, and to affect EpoR phosphorylation 11 .
Epo-induced activation of p60-Src in EpoR-HM, EpoR-H and wt-EpoR erythroblasts therefore was analyzed. Via the wt-EpoR, p60-Src was activated several-fold, and maximally so at 8 minutes of Epo stimulation ( Figure 2C ). In cytokine-deprived wt-EpoR cells, background levels of activated p60-Src, however, were sustained (as contrasted with Jak2 and Stat5, for example). In EpoR-HM erythroblasts, Little to no JNK activation was detected however via EpoR-HM or EpoR-H alleles. ERKs, in contrast, proved to be induced via each Epo receptor allele, but interestingly were discovered to be selectively hyper-activated via the PY-null EpoR-HM allele ( Figure 3B-1 ). This latter finding was also examined further, and was confirmed, in Ter119 pos -depleted erythroblast preparations ( Figure 3B -2).
Faltered late-stage development of EpoR-HM erythroblasts, and rescue by PY343 signals or MEK1,2 inhibition
The limited signal transduction capacities observed for EpoR-HM in primary erythroblasts prompted additional follow-up biofunctional investigations. Compromised erythropoiesis often induces elevated Epo production. Epo levels in EpoR-HM, EpoR-H and wt-EpoR mice therefore were first assessed.
RT-PCR analysis of renal Epo transcript levels provided high sensitivity and reproducibility, and was employed. In EpoR-HM mice, Epo levels were elevated on-average to 1.9-fold above wt-EpoR controls. By direct comparison, levels in EpoR-H mice were decreased to approximately 60 % of wildonly.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From type. These differences were uniformly observed in all mice assayed (n=3 per group) and were significant at a level of p<0.01 (Table 2) . Second, Epo-induced reticulocyte production in response to Epo dosing was assayed. Mice were injected twice with Epo (2.5U/g), and reticulocytes were assayed on day 5. Levels in EpoR-HM mice were diminished several-fold as compared to wild-type congenic controls, and to EpoR-H mice ( Figure 4A ). Third, late-stage development of EpoR-HM and EpoR-H erythroblasts was analyzed in vitro. In brief, this involved expansion for 3 days, followed by culture in a differentiation medium containing transferrin, insulin and Epo. For -HM) . In pilot experiments, U0126 at 10μM was observed to have little effect on expansion (but at 20μM detectably affected viability, data not shown). EpoR-HM, EpoR-H and wt-EpoR erythroblasts therefore were expanded in the presence of 10μM U0126 and then shifted to differentiation medium. Upon differentiation, U0126 proved to essentially correct dysregulated EpoR-HM erythroblast maturation as revealed first by clear decreases in forward-angle light scatter ( Figure 6A ). As assayed based on Ter119 and CD71 marker expression, U0126 also promoted the maturation of a sub-population of EpoR-HM Ter119 pos CD71 low erythroblasts ( Figure 6B ). In contrast, U0126 at this dose had no significant effects on the maturation of wt-EpoR erythroblasts (or on EpoR-H erythroblasts, data not shown). Dose-dependency of this U0126 effect on EpoR-HM erythroblasts also is illustrated ( Figure   6C ). The capacity of U0126 to inhibit EpoR-mediated ERK activation also was assessed directly in (SB600125), no significant effects were observed (data not shown).
EpoR-H and EpoR-HM erythroblast survival potential, and Bcl-x, Bax and DAPK2 expression
Based on Epo's primary role as an anti-apoptotic factor 43 , possible differences among EpoR-HM,
EpoR-H and wt-EpoR erythroblast survival, and Bcl-xl, Bax and DAPK-2 expression were analyzed ( Figure 7) . In expanded EpoR-HM erythroblasts, Bcl-xl levels proved to be decreased several-fold (Figure 7-A1) . Bax expression levels, by comparison, were similar for each EpoR allele. In repeated only.
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DISCUSSION
As revealed through transgenic mouse models, the EpoR is essential for erythroblast formation 45 , and its conditional hematopoietic expression is sufficient for normal overall development 45 .
Crystallographic and structural analyses have provided detailed insight into Epo-mediated dimerization of its receptor 2, 46 , and conformation-dependent mechanisms of Jak2 activation 3 . Epo signal transduction studies also have gone far to define a broad, yet select set of factors and associated pathways that mediate and/or modulate Epo's actions as a clinically important anti-anemia agent 47,48 .
The present work uses mice with knocked-in minimal EpoR alleles and primary marrow-derived erythroblasts to further define core signal transduction events which are integral to Epo receptor function.
A minimal model for EpoR action is one whereby Jak2 fulfills a central role, and supports Epo action independently from EpoR PY modulating effects. This model is predicted by the in vivo erythropoietic capacity of EpoR-HM, and has previously been framed in cell line models. Specifically, EpoR-HM has been reported in 32D cells to induce Bcl-x and c-Myc expression 49,50 , and to support ERK activation at wild-type levels 51 . In the present investigations we analyzed EpoR-HM's capacity in primary erythroblasts to activate Jak2, Stat5, Stat5-target genes, Bcl-x and Myc (see below). We also examined possible EpoR-HM regulation of Akt, p70S6-kinase, p60Src, p38-MAPK, JNKs and ERKs. Jak2 activation profiles were essentially normal, and in the absence of PY343, no significant induction of Stat5, or Stat5-target genes was detected. In addition, EpoR-HM essentially failed to activate JNKs or p70S6-kinase, and was substantially compromised in its ability to simulate Akt (as well as p60-Src).
As observed for the wt-EpoR (and EpoR-H), EpoR-HM modestly stimulated p38-MAPK. For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From erythroblasts upon exposure to the MEK1,2 inhibitor U0126 (see Figure 6) . It is noted, however, that chronic activation of ERKs also can induce apoptosis 64 , and this response also might contribute to the elevated apoptosis observed among maturing EpoR-HM cells. Finally, for EpoR-HM, two additional responses described previously in cell line models are c-Myc, and Bcl-x transcript induction 49, 50 . In the present system, c-Myc (and n-Myc) induction by Epo was analyzed. Each was up-modulated approximately 1.5-fold uniformly in EpoR-HM, EpoR-H and wt-EpoR erythroblasts (unpublished results). This therefore was not a strong or differential response. For Bcl-x, possible regulation via EpoR alleles is discussed below.
In EpoR-H erythroblasts, the selective restoration of PY343 restored efficient Epo-activation of Stat5
(and also increased p60-Src activation). As indicated above, ERK activation also was down-modulated as compared to EpoR-HM (to approximately wt-EpoR levels). JNK and p70S6 kinases, however, remained essentially uncoupled, and Akt activation also was inefficient (as observed for EpoR-HM). For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From appears to increase erythroid progenitor cell proliferative potential 73 . In primary erythroblasts, Epo appears to activate at least two JNK isoforms, but this proved to depend upon EpoR carboxyl-terminal PY sites beyond PY343. Factors that link the EpoR to MEK4/7 and JNK pathways remain to be discovered, as do the contributions of this typically stress-activated module to erythropoiesis.
Overall, the present studies reveal that core Jak2-mediated, Epo receptor PY-independent signals for erythroblast formation are associated primarily with PY-null EpoR-HM activation of ERKs, and are EpoR-H's activity (and that of the wt-EpoR) therefore may more likely depend upon the actions of one or more key Stat5-target genes in developing erythroblasts. Two candidate targets are Pim-1 and oncostatin-M, but others are being actively sought using the presently developed primary erythroblast system.
p70S6-kinase activation via the wt-EpoR, but not EpoR-H or EpoR-HM -Erythroblasts from wt-
EpoR, EpoR-HM and EpoR-H mice were expanded, washed, cultured for 6 hours in the absence of cytokines, and then stimulated for the indicated intervals with Epo (2.5U/mL). Lysates then were prepared and levels of phosphorylated and total p70S6-kinase were assayed by western blotting. For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From above cells and samples (panel B), levels of phospho-p60-Src (and p60-Src) were assayed by western blotting (and digital densitometry imaging). C-3] Differential PP2 inhibition of EpoR-HM, EpoR-H and wt-EpoR erythroblast expansion -During in vitro expansions, wt-EpoR, EpoR-H, and EpoR-HM erythroblasts were exposed to 15uM PP2. Effects on erythroblast formation were assessed by direct cumulative cell counts at day-3 of expansion, and are normalized to numbers for parallel DMSOexposed control cultures. PP3 also was tested, but was without significant effects (data not shown). For For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From
B] Deficient Akt activation via EpoR-HM and EpoR-H alleles
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